Basima A.A. Saleem

Dr. Basima A.A. Saleem

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 March 2026 in Molecules
Verified
Journal Article
Open access
PDF file
Basima A.A. SaleemBasima A.A. Saleem
Basima A.A. Saleem
AQAshraf Ahmed Qurtam
Ashraf Ahmed Qurtam
MEMohamed El-Mokhtar
Mohamed El-Mokhtar
RARaed Fanoukh Aboqader Al-Aouadi
Raed Fanoukh Aboqader Al-Aouadi
AAAli Abdulrazzaq Abdulhussein Alrikabi
Ali Abdulrazzaq Abdulhussein Alrikabi
SFsara mahmoud farhan
sara mahmoud farhan
Multitarget-directed ligands offer a promising strategy for overcoming tumor complexity through simultaneous modulation of complementary oncogenic pathways. In this work, a novel (E)-6-(3-(4-methyl-2-thioxo-2,3-dihydrothiazol-5-yl)-3-oxoprop-1-en-1-yl)-2H-chromen-2-one (compound 6) was synthesized and evaluated as a dual inhibitor of tubulin polymerization and tumor-associated carbonic anhydrases (CAs) IX and XII. Compound 6 displayed potent antiproliferative activity, particularly against MDA-MB-231 triple-negative breast cancer cells (IC50 = 0.37 µM), with excellent selectivity toward non-tumorigenic cells. Mechanistic studies demonstrated strong tubulin polymerization inhibition (IC50 = 3.40 ± 0.09 µM) and submicromolar inhibition of CA IX (IC50 = 0.102 ± 0.005 µM) and CA XII (IC50 = 0.213 ± 0.004 µM), accompanied by downregulation of CA-IX and CA-XII protein expression. Cellular investigations revealed pronounced G2/M phase arrest and apoptosis induction via mitochondrial signaling and caspase activation. Anti-angiogenic activity was supported by inhibition of endothelial migration and concentration-dependent suppression of VEGFR-2 (Tyr1175) phosphorylation in HUVEC cells. Human liver microsomal assays indicated measurable metabolic stability, while molecular docking and in silico ADMET predictions supported target engagement and drug-like properties. Collectively, these findings identify compound 6 as a promising multitarget anticancer lead integrating antimitotic, metabolic, and anti-angiogenic mechanisms.

19 December 2024 in Journal of the Indian Chemical Society
Verified
Journal Article
Closed access
Basima A.A. SaleemBasima A.A. Saleem
Basima A.A. Saleem
SMSalim A. Mohammed
Salim A. Mohammed
AAAmer Th. Al-Taee
Amer Th. Al-Taee

10 February 2021 in Materials Today: Proceedings
Verified
Journal Article
Closed access
Basima A.A. SaleemBasima A.A. Saleem
Basima A.A. Saleem
SMSahbaa Y. Majeed
Sahbaa Y. Majeed

2 June 2026 in RSC Advances
Verified
Journal Article
Open access
PDF file
Basima A.A. SaleemBasima A.A. Saleem
Basima A.A. Saleem
AQAshraf Ahmed Qurtam
Ashraf Ahmed Qurtam
ASAbdelrahman R. Shalabi
Abdelrahman R. Shalabi
FNFahd A A Nasr
Fahd A A Nasr
Kasim Sakran AbassKasim Sakran Abass
Kasim Sakran Abass
AAAbdullah Alkhammash
Abdullah Alkhammash
A novel series of pyrazole/thiazole chalcone hybrids (9a–o) was designed, synthesized, and evaluated as dual tubulin/COX-2 inhibitors with anticancer activity. The synthesized compounds were screened for antiproliferative activity against MDA-MB-231, HCA-7, and A549 cancer cell lines. Several derivatives exhibited promising activity, with 9m being the most potent against MDA-MB-231 cells (IC50 = 1.96 ± 0.10 µM), while 9l emerged as the most balanced lead compound, showing strong antiproliferative activity against HCA-7, MDA-MB-231, and A549 cells with IC50 values of 2.18 ± 0.11, 2.92 ± 0.15, and 4.86 ± 0.25 µM, respectively. Mechanistic studies revealed that the anticancer activity of this series is mediated through a dual mechanism involving tubulin polymerization inhibition and selective COX-2 inhibition. In particular, compound 9l inhibited tubulin polymerization with an IC50 of 4.21 ± 0.25 µM and showed potent COX-2 inhibition (IC50 = 0.10 ± 0.01 µM) with high selectivity over COX-1 (IC50 = 10.92 ± 0.78 µM; selectivity index = 109.20). Further investigation in HCA-7 cells demonstrated that 9l significantly increased Bax level to 438.64 ± 15.72 pg mL−1 and reduced Bcl-2 to 6.74 ± 0.19 pg mL−1, while markedly elevating caspase-3 and caspase-9 levels to 496.80 ± 14.90 pg mL−1 and 47.86 ± 1.18 ng mL−1, respectively. Moreover, 9l strongly suppressed PGE-2 production to 0.56 ± 0.04 ng mL−1, corresponding to 89.2% inhibition, and induced G2/M cell-cycle arrest. It also showed promising anti-migratory activity in the wound-healing assay, favorable microsomal stability, and acceptable in silico ADMET properties. Molecular docking further supported its favorable binding within the active sites of both tubulin and COX-2. Collectively, these findings identify 9l as a promising dual tubulin/COX-2-targeting anticancer candidate.


1 November 2021 in Journal of Pharmaceutical Research International
Verified
Journal Article
Closed access
PDF file
Basima A.A. SaleemBasima A.A. Saleem
Basima A.A. Saleem
EHEnaam A. Hamdon
Enaam A. Hamdon
SMSahbaa Y. Majeed
Sahbaa Y. Majeed
Aims: Design of technical methods for the determination of Furosemide in its pure and pharmaceutical dosage form using spectral methods. Study Design: planned and executed to estimate Furosemide by using Visible spectrophotometric in pure and pharmaceutical dosage form. Place and Duration of Study: Laboratory of Analytical Research, chemistry department, college of Science, University of Mosul ,Mosul-Iraq, during the period of April 2021 to August 2021. Methodology: Furosemide, the commercially known drug Lazix, which is important in the treatment of heart diseases and high blood pressure. This study was carried out using JASCO V – 630, double-beam computerized UV-Visible spectrophotometer, with 1 cm matched cell, and HANA pH meter was used for reported pH readings. Results: The reaction between Furosemide and bromo-phenol blue, xylenol orange, and chromazorol S. The decreasing in the intensity of the resulted colored complex was measured using bromo-phenol blue, xylenol orange, While the increasing of the color intensity was measured in the method (C). These three methods were based on charge transfer reaction. The limits of Beer's law for method (A) 0.4-32µg. mL-1, method (B) 1-32 and method (C) were 0.8-32 depending on the level of concentration, while the values ​​of the molar absorption coefficient 1.4×104, 2.1×104 and 1.57×104 l.mol-1.cm-1 for the first, second and third method respectively. Sandel's significance also was calculated for these three methods, 0.0157 μg.cm-2 for the first method, 0.0236 μg.cm-2 for the second method, while the third method was 0.0210 μg.cm-2. The method has been successfully applied for the determination of furosemide in its pure form and in some of its pharmaceutical preparations Conclusion: The proposed methods were validated in terms of linearity, range, Accuracy, precision, Specificity, Robustness. The proposed methods were successfully applied to the estimation of Furosemide in pharmaceutical dosage form, method (B) was experimentally considered as a best method depending on the best values of molar absorptivity, stability of the resulted complex, and the linearity of the method (B) .